Log In
Print this Print this

Sivextro, tedizolid phosphate (IV Sivextro) (TR-701) (formerly DA-7218, torezolid phosphate)

  Manage Alerts
Collapse Summary General Information
Company Dong-A Pharmaceutical Co. Ltd.
DescriptionSecond-generation oxazolidinone, a bacterial protein biosynthesis inhibitor
Molecular Target Ribosomal 50S subunit
Mechanism of ActionProkaryotic protein synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSkin and skin structure infection (SSSI)
Indication DetailsTreat acute bacterial skin and skin structure infection (ABSSSI); Treat complicated skin and skin structure infection (cSSSI)
Regulatory Designation


Bayer AG; Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today